Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22223855.
- Also identified by DOI 10.1093/infdis/jir788.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concerns have arisen about possible effects of protease inhibitors (PIs) on cardiac conductivity. We found no significant association between current or recent PI exposure and sudden death or nonhemorrhagic stroke (adjusted rate ratio, 1.22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11).
Medical subject headings
- Death, Sudden
- HIV Infections
- HIV Protease Inhibitors
- Stroke